GLP-1-S

Description

CAS Number: 910463-68-2

Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Molecular Weight: Approximately 4113.58–4114 g/mol (a large 31-amino-acid peptide)

GLP1-S is a synthetic 31–amino-acid peptide analog featuring a C18 fatty-acid side-chain conjugation that enhances structural stability and supports predictable conformational behavior during analytical evaluation. Its sequence includes targeted amino-acid substitutions characteristic of long-acting incretin-family peptides. Semaglutide is commonly examined in research settings for studies involving peptide–lipid conjugation, chromatographic profiling, and stability analysis of modified large-peptide structures.

Mechanism of Action

GLP-1 receptors, leading to glucose-dependent effects that minimize hypoglycemia risk:

• Stimulates insulin secretion from pancreatic beta cells when blood glucose is high.
• Suppresses glucagon release from alpha cells (reducing hepatic glucose production).
• Slows gastric emptying, promoting satiety and reducing post-meal glucose spikes.
• Acts centrally to decrease appetite and food intake.

*Reconstitution Needed for Lyophilized Powder*

Use a diluent such as Bacteriostatic Water / Reconstitution Solution. NOT INCLUDED. MUST BE ORDERED SEPARATELY.

AvivaAmino is pleased to offer this product exclusively for research and laboratory use, provided in a lyophilized (freeze-dried) powder form to ensure its stability and integrity. It is important to understand that, in line with regulatory standards, we are unable to provide specific dosing instructions or reconstitution guidelines. 

The dosage information listed on the product label reflects the total quantity of material within the vial. 

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. PURCHASE IMPLIES ACKNOWLEDGEMENT OF THESE RESTRICTIONS. ALL PRODUCTS ARE RESEARCH CHEMICALS AND MUST BE HANDLED BY QUALIFIED PROFESSIONALS.